AAAAAA
Results: 26-50/1748
Authors:
Walmsley, S
Citation: S. Walmsley, Valganciclovir - A viewpoint by Sharon Walmsley, DRUGS, 61(8), 2001, pp. 1151-1151
Authors:
Pescovitz, MD
Citation: Md. Pescovitz, Valganciclovir - A viewpoint by Mark D. Pescovitz, DRUGS, 61(8), 2001, pp. 1151-1152
Authors:
McGavin, JK
Goa, KL
Citation: Jk. Mcgavin et Kl. Goa, Ganciclovir - An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients, DRUGS, 61(8), 2001, pp. 1153-1183
Authors:
Wellington, K
McClellan, K
Jarvis, B
Citation: K. Wellington et al., Reviparin - A review of its efficacy in the prevention and treatment of venous thromboembolism, DRUGS, 61(8), 2001, pp. 1185-1209
Authors:
Matheson, AJ
Cheer, SM
Goa, KL
Citation: Aj. Matheson et al., Perindopril/indapamide 2/0.625 mg/day - A review of its place in the management of hypertension, DRUGS, 61(8), 2001, pp. 1211-1229
Authors:
Hite, RD
Morris, PE
Citation: Rd. Hite et Pe. Morris, Acute respiratory distress syndrome - Pharmacological treatment options indevelopment, DRUGS, 61(7), 2001, pp. 897-907
Authors:
Torrisi, R
Decensi, A
Formelli, F
Camerini, T
De Palo, G
Citation: R. Torrisi et al., Chemoprevention of breast cancer with fenretinide, DRUGS, 61(7), 2001, pp. 909-918
Authors:
Sparr, HJ
Beaufort, TM
Fuchs-Buder, T
Citation: Hj. Sparr et al., Newer neuromuscular blocking agents - How do they compare with establishedagents?, DRUGS, 61(7), 2001, pp. 919-942
Authors:
Ruzicka, M
Leenen, FHH
Citation: M. Ruzicka et Fhh. Leenen, Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension, DRUGS, 61(7), 2001, pp. 943-954
Authors:
Ripamonti, C
Dickerson, ED
Citation: C. Ripamonti et Ed. Dickerson, Strategies for the treatment of cancer pain in the new millennium, DRUGS, 61(7), 2001, pp. 955-977
Authors:
Brent, J
Citation: J. Brent, Current management of ethylene glycol poisoning, DRUGS, 61(7), 2001, pp. 979-988
Authors:
Malhotra, HS
Plosker, GL
Citation: Hs. Malhotra et Gl. Plosker, Barnidipine, DRUGS, 61(7), 2001, pp. 989-996
Authors:
Ruilope, LM
Citation: Lm. Ruilope, Barnidipine - A viewpoint, DRUGS, 61(7), 2001, pp. 997-997
Authors:
Saruta, T
Citation: T. Saruta, Barnidipine - A viewpoint, DRUGS, 61(7), 2001, pp. 997-998
Authors:
Sharpe, M
Noble, S
Spencer, CM
Citation: M. Sharpe et al., Alendronate - An update of its use in osteoporosis, DRUGS, 61(7), 2001, pp. 999-1039
Authors:
Barclay, ML
Begg, EJ
Citation: Ml. Barclay et Ej. Begg, Aminoglycoside adaptive resistance - Importance for effective dosage regimens, DRUGS, 61(6), 2001, pp. 713-721
Authors:
Cox, AD
Citation: Ad. Cox, Farnesyltransferase inhibitors - Potential role in the treatment of cancer, DRUGS, 61(6), 2001, pp. 723-732
Authors:
Pisoni, R
Ruggenenti, P
Remuzzi, G
Citation: R. Pisoni et al., Renoprotective therapy in patients with nondiabetic nephropathies, DRUGS, 61(6), 2001, pp. 733-745
Authors:
Smith, A
Pennefather, PM
Kaye, SB
Hart, CA
Citation: A. Smith et al., Fluoroquinolones - Place in ocular therapy, DRUGS, 61(6), 2001, pp. 747-761
Authors:
Alvarez-Lerma, F
Palomar, M
Grau, S
Citation: F. Alvarez-lerma et al., Management of antimicrobial use in the intensive care unit, DRUGS, 61(6), 2001, pp. 763-775
Authors:
McClellan, K
Perry, CM
Citation: K. Mcclellan et Cm. Perry, Oseltamivir: a review of its use in influenza (vol 61, pg 263, 2001), DRUGS, 61(6), 2001, pp. 775-775
Authors:
Bousvaros, A
Mueller, B
Citation: A. Bousvaros et B. Mueller, Thalidomide in gastrointestinal disorders, DRUGS, 61(6), 2001, pp. 777-787
Authors:
McClellan, K
Jarvis, B
Citation: K. Mcclellan et B. Jarvis, Desloratadine, DRUGS, 61(6), 2001, pp. 789-796
Authors:
Day, JH
Rafeiro, E
Citation: Jh. Day et E. Rafeiro, Desloratadine, DRUGS, 61(6), 2001, pp. 797-797
Authors:
Bernstein, DI
Citation: Di. Bernstein, Desloratadine, DRUGS, 61(6), 2001, pp. 797-797